Oligonucleotide agonists targeting progranulin

The present invention relates to oligonucleotides which up-regulate or restore the expression of progranulin in cells, and their use in the treatment of neurological disorders, and disorders associated with progranulin haploinsufficiency.

Saved in:
Bibliographic Details
Main Authors JAGASIA, RAVI, WORM, JESPER, LARSEN, DORTHE VANG, RASMUSSEN, SOREN, TEHLER, DISA, JOENSON, LARS
Format Patent
LanguageChinese
English
Published 01.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to oligonucleotides which up-regulate or restore the expression of progranulin in cells, and their use in the treatment of neurological disorders, and disorders associated with progranulin haploinsufficiency.
AbstractList The present invention relates to oligonucleotides which up-regulate or restore the expression of progranulin in cells, and their use in the treatment of neurological disorders, and disorders associated with progranulin haploinsufficiency.
Author LARSEN, DORTHE VANG
RASMUSSEN, SOREN
TEHLER, DISA
JAGASIA, RAVI
JOENSON, LARS
WORM, JESPER
Author_xml – fullname: JAGASIA, RAVI
– fullname: WORM, JESPER
– fullname: LARSEN, DORTHE VANG
– fullname: RASMUSSEN, SOREN
– fullname: TEHLER, DISA
– fullname: JOENSON, LARS
BookMark eNrjYmDJy89L5WTQ88_JTM_PK03OSc0vyUxJVUgE8jKLS4oVShKL0lNLMvPSFQqK8tOLEvNKczLzeBhY0xJzilN5oTQ3g6Kba4izh25qQX58anFBYnJqXmpJfEi4kYGRkYGFmZGFozExagBaPC1n
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW202208628A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW202208628A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:21:55 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW202208628A3
Notes Application Number: TW202110117294
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220301&DB=EPODOC&CC=TW&NR=202208628A
ParticipantIDs epo_espacenet_TW202208628A
PublicationCentury 2000
PublicationDate 20220301
PublicationDateYYYYMMDD 2022-03-01
PublicationDate_xml – month: 03
  year: 2022
  text: 20220301
  day: 01
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies F. HOFFMANN-LA ROCHE AG
RelatedCompanies_xml – name: F. HOFFMANN-LA ROCHE AG
Score 3.514466
Snippet The present invention relates to oligonucleotides which up-regulate or restore the expression of progranulin in cells, and their use in the treatment of...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Title Oligonucleotide agonists targeting progranulin
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220301&DB=EPODOC&locale=&CC=TW&NR=202208628A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU82T0s2N0_TTUxKTAN2UJLTgHku2VTXElhZp5kamlkYpIFmdH39zDxCTbwiTCOYGLJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3bGQEauGruTjZugb4u_g7qzk724aEq_kFQeSArXcLR2YGVmAz2hyUG1zDnEC7UgqQqxQ3QQa2AKBpeSVCDExVGcIMnM6wm9eEGTh8oRPeQCY07xWLMOj552Sm5-eBzh_OLwE6XSERyAPqKFaArOYG1kEKkNVWeaDV5aIMim6uIc4eukCL4-G-jA8JR7jRWIyBBdj7T5VgUEhKTjQxMgedmm6QamKRaJBoapmSaploaWmeZJmYlmYhySCF2xwpfJLSDFwgDmRBlQwDS0lRaaossIYtSZIDBw0A0uaBFw
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU82T0s2N0_TTUxKTAN2UJLTgHku2VTXElhZp5kamlkYpIFmdH39zDxCTbwiTCOYGLJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3bGQEauGruTjZugb4u_g7qzk724aEq_kFQeSArXcLR2YGVmAT2wJ024FrmBNoV0oBcpXiJsjAFgA0La9EiIGpKkOYgdMZdvOaMAOHL3TCG8iE5r1iEQY9_5zM9Pw80PnD-SVApyskAnlAHcUKkNXcwDpIAbLaKg-0ulyUQdHNNcTZQxdocTzcl_Eh4Qg3GosxsAB7_6kSDApJyYkmRuagU9MNUk0sEg0STS1TUi0TLS3NkywT09IsJBmkcJsjhU9SnoHTI8TXJ97H089bmoELJAFZXCXDwFJSVJoqC6xtS5LkwMEEAAijhAc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Oligonucleotide+agonists+targeting+progranulin&rft.inventor=JAGASIA%2C+RAVI&rft.inventor=WORM%2C+JESPER&rft.inventor=LARSEN%2C+DORTHE+VANG&rft.inventor=RASMUSSEN%2C+SOREN&rft.inventor=TEHLER%2C+DISA&rft.inventor=JOENSON%2C+LARS&rft.date=2022-03-01&rft.externalDBID=A&rft.externalDocID=TW202208628A